Lupin and SunPharma Launch Generic Favipiravir to Treat Mild to Moderate COVID-19 in India
- Lupin has launched favipiravir in India under the brand name ‘Covihalt’ for the treatment of mild to moderate COVID-19
- Covihalt will be available as 200mg tablets in the form of a strip of 10 tablets- priced at $0.65 (₹49/tablet) and has received DCGI authorization for emergency use
- Additionally- SunPharma has launched antiviral drug favipiravir under the brand name 'FluGuard' to treat mild to moderate cases of COVID-19- at ₹35/tablet in India
Lupin- SunPharma | Image: StraitTimes
Click here to read the full press release
Tuba was Senior Editor at PharmaShots. She was curious, creative, and passionate about recent updates and innovations in the life sciences industry. She covered Biopharma, MedTech, and Digital health segments. Tuba also had an experience in digital and social media marketing and ran the campaigns independently. She can be contacted at [email protected].